NCT06766474View on ClinicalTrials.gov

The Rule of Bupivacaine Hydrochloride in Skin Graft Donor Site

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

October 15, 2024

Study Completion Date

October 30, 2024

Conditions
Skin Graft ComplicationsPain Management
Interventions
DRUG

Bupivacain

to our knowledge, this study is the 1st to compare the efficacy of bupivacaine hydrochloride-soaked dressing versus subcutaneous infiltration for postoperative donor site pain control for patients undergoing STSG procedures.

Trial Locations (1)

61519

Minia University Hospital, Minya

All Listed Sponsors
lead

Minia University

OTHER